Nanoscope Therapeutics: Funding, Investors & Team (Oct 2026)
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. They utilize ambient light-sensitive molecules to re-sensitize the retina toward a low light level. Its light-assisted gene therapy is highly targeted to geographic atrophies without perturbing the intact retina circuitry.
Nanoscope Therapeutics has raised $1.5M across 1 funding round on record, the most recent a Grant of $1.5M announced in Sep 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nanoscope Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2021.
Nanoscope Therapeutics Funding Rounds
Nanoscope Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Nanoscope Therapeutics Funding Compared to Other Biotechnology Startups
Nanoscope Therapeutics' latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nanoscope Therapeutics in Biotechnology and Bedford
Companies Similar to Nanoscope Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Nanoscope Therapeutics Funding FAQs
What does Nanoscope Therapeutics do?
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. They utilize ambient light-sensitive molecules to re-sensitize the retina toward a low light level. Its light-assisted gene therapy is highly targeted to geographic atrophies without perturbing the intact retina circuitry.
How much funding has Nanoscope Therapeutics raised?
Nanoscope Therapeutics has raised $1.5M across 1 round on record. The most recent is a Grant of $1.5M announced in Sep 2021.
When did Nanoscope Therapeutics last raise funding?
Nanoscope Therapeutics' most recent funding round on record is a Grant of $1.5M, announced in Sep 2021.
Who is the CEO of Nanoscope Therapeutics?
Sulagna Bhattacharya is listed as CEO at Nanoscope Therapeutics.
Where is Nanoscope Therapeutics headquartered?
Nanoscope Therapeutics is based in Bedford, Texas, United States.
How many employees does Nanoscope Therapeutics have?
Nanoscope Therapeutics is in the 1-10 employee band.
How does Nanoscope Therapeutics' funding compare to other Biotechnology startups?
Nanoscope Therapeutics' latest round of $1.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Nanoscope Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nanoscope Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.